Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND · Real-Time Price · USD

319.43

-0.99 (-0.31%)

At close: Jul 7, 2026, 4:00 PM EDT

318.00

-1.43 (-0.45%)

After-hours: Jul 7, 2026, 5:06 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Revenue from Intangible Royalty Assets	143.88M	132.53M	95.33M
Revenue from Intangible Royalty Assets Growth	8.56%	39.03%	13.61%
Income from Financial Royalty Assets	32.59M	28.47M	13.44M
Income from Financial Royalty Assets Growth	14.49%	111.75%	1181.60%
Royalties Revenue	176.47M	161.00M	108.77M
Royalties Revenue Growth	9.61%	48.02%	28.03%
Captisol Revenue	35.41M	40.21M	30.88M
Captisol Revenue Growth	-11.95%	30.21%	8.85%
Contract Revenue and Income	62.60M	66.87M	27.48M
Contract Revenue and Income Growth	-6.39%	143.38%	52.79%
Revenue (Total)	274.48M	268.09M	167.13M
Revenue (Total) Growth	2.38%	60.40%	27.28%